TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07618299: Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

Sponsor: Meitheal Pharmaceuticals, Inc. · Phase: PHASE4 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 24 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$3,160,640

Rescue Site Savings

+$2,098,240

Unlock Full NCT07618299 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07618299 Rescue Dossier →